lower price Memantine（19982-08-2） supply

Details:

• Name		Memantine
  Synonyms		1,3-Dimethylaminoadamantane; 3,5-Dimethyl-1-aminoadamantane; 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine
  Molecular Structure
  Molecular Formula		C12H21N
  Molecular Weight		179.30
  CAS Registry Number		19982-08-2 (51052-62-1)
  Properties
  Density		1.046
  Safety Data
  Safety Description		S24/25    Details

  MF: C₁₂H₂₁N
  Density: 1.046 g/cm³
  Flash Point: 92.3 °C
  MW: 179.301840 g/mol 
  Product Name: Memantine 
  IUPAC: 3,5-dimethyladamantan-1-amine
  Boiling Point: 239.8 °C at 760 mmHg
  Enthalpy of Vaporization: 47.67 kJ/mol
  Vapour Pressure: 0.0393 mmHg at 25°C 
  Synonyms: AKOS BB-9600 ; MEMANTINE ; AURORA KA-7643 ; TIMTEC-BB SBB002574 ; 3,5-dimethyladamantan-1-amine HCl ; 1-Amino-3,5-dimethyladamantane ; 3,5-Dimethyl-1-aminoadamantane ; 3,5-DIMETHYL-1-AMINOADAMANTANE( MEMANTINE )
  Following is the molecular structure of Memantine (19982-08-2):
  
  
  
   

  Memantine was first synthesized and patented by Eli Lilly and Company in 1968 (as cited in the Merck Index), and then developed by Merz  in collaboration with Neurobiological Technologies, Inc. and licensed to Forest for the U.S. and Lundbeck for selected European and international markets.

  
  Memantine has been associated with a moderate decrease in clinical deterioration in Alzheimer's disease.A systematic review of randomised controlled trials found that memantine has a small positive effect on cognition, mood, behaviour, and the ability to perform daily activities in moderate to severe Alzheimer's disease, but an unknown effect in mild to moderate disease.
  Memantine is also being tested for opioid dependence, systemic lupus erythematosus, depression, obsessive compulsive disorder, Tourette Syndrome, problem gambling, attention-deficit hyperactivity disorder (ADHD),glaucoma, tinnitus, neuropathic pain including Complex Regional Pain Syndrome, pervasive developmental disorders, HIV associated dementia, nystagmus, and multiple sclerosis.

  Safety Information of Memantine (19982-08-2):